BACKGROUND: This study estimates prevalence, management, and relief of pain during the last 3 months of life of a representative sample of dying cancer patients in Italy. PATIENTS AND METHODS: This is a mortality follow-back survey (the Italian Survey of the Dying of Cancer). Caregivers were interviewed, after the patient's death, about pain experienced by the patients in all settings of care. RESULTS: According to caregivers' reports, 82.3% [95% confidence interval (CI) 79.9% to 84.4%] patients experienced pain, and 61.0% (95% CI 57.9% to 64.0%) very distressing pain. The younger population experienced a higher prevalence of pain in respect to older patients (P < 0.01). Patients with tumors of the central nervous system experienced the lowest prevalence (51.9%). According to caregivers' reports, only 59.5% (95% CI 3.7% to 65.0%) received analgesic treatment with opioids for moderate to severe pain. Not surprisingly, pain was 'only partially relieved' or 'not relieved at all' in 54% of the patients with very distressing pain. CONCLUSIONS: Although potentially slightly biased, the results from this survey regarding undermedication and poor treatment results for cancer related pain are unequivocal. The research agenda should focus on testing the effectiveness of interventions to improve the quality of pain assessment and management.
BACKGROUND: This study estimates prevalence, management, and relief of pain during the last 3 months of life of a representative sample of dying cancerpatients in Italy. PATIENTS AND METHODS: This is a mortality follow-back survey (the Italian Survey of the Dying of Cancer). Caregivers were interviewed, after the patient's death, about pain experienced by the patients in all settings of care. RESULTS: According to caregivers' reports, 82.3% [95% confidence interval (CI) 79.9% to 84.4%] patients experienced pain, and 61.0% (95% CI 57.9% to 64.0%) very distressing pain. The younger population experienced a higher prevalence of pain in respect to older patients (P < 0.01). Patients with tumors of the central nervous system experienced the lowest prevalence (51.9%). According to caregivers' reports, only 59.5% (95% CI 3.7% to 65.0%) received analgesic treatment with opioids for moderate to severe pain. Not surprisingly, pain was 'only partially relieved' or 'not relieved at all' in 54% of the patients with very distressing pain. CONCLUSIONS: Although potentially slightly biased, the results from this survey regarding undermedication and poor treatment results for cancer related pain are unequivocal. The research agenda should focus on testing the effectiveness of interventions to improve the quality of pain assessment and management.
Authors: J A F Koekkoek; L Dirven; E M Sizoo; H R W Pasman; J J Heimans; T J Postma; L Deliens; R Grant; S McNamara; G Stockhammer; E Medicus; M J B Taphoorn; J C Reijneveld Journal: J Neurooncol Date: 2014-08-24 Impact factor: 4.130
Authors: Hye-Suk Han; Ki Hyeong Lee; Kyung Hee Lee; Jeong Seon Ryu; Young Chul Kim; Seung Woo Park; Ho-Suk Oh; Kyung Tae Park; Jung Hye Kwon; Pyung Bok Lee; Won Sik Lee; Yang Soo Kim; Joong Bae Ahn; Seong Woo Jeon; Sung Yong Lee; Young Mi Seol; Jung Hun Kang; Young Jin Yuh; So Yeon Oh; Suk Ran Kim; Jin Seok Ahn Journal: Support Care Cancer Date: 2013-11-08 Impact factor: 3.603
Authors: N A Hagen; B Lapointe; M Ong-Lam; B Dubuc; D Walde; B Gagnon; R Love; R Goel; P Hawley; A Ho Ngoc; P du Souich Journal: Curr Oncol Date: 2011-06 Impact factor: 3.677
Authors: Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh Journal: Pain Date: 2011-09-09 Impact factor: 6.961
Authors: Lara Dhingra; Kin Lam; Peter Homel; Jack Chen; Victor T Chang; Juanyi Zhou; Selina Chan; Wan Ling Lam; Russell Portenoy Journal: Oncologist Date: 2011-03-14
Authors: Francesco De Logu; Matilde Marini; Lorenzo Landini; Daniel Souza Monteiro de Araujo; Niccolò Bartalucci; Gabriela Trevisan; Gennaro Bruno; Martina Marangoni; Brian L Schmidt; Nigel W Bunnett; Pierangelo Geppetti; Romina Nassini Journal: Cancer Res Date: 2021-03-26 Impact factor: 12.701